Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05249257 · ClinicalTrials.gov registry record
Durability and Safety of CCH With Two Different Injection Techniques in Cellulite With Laxity
A clinical trial, sponsored by Endo USA Inc., a Keenova Therapeutics Company.
- Completed
- Registry status
- 20
- Enrollment target
NCT05249257: Completed study, sponsored by Endo USA Inc., a Keenova Therapeutics Company.
NCT05249257 is a clinical trial that has completed, run by Endo USA Inc., a Keenova Therapeutics Company. The registered enrollment target is 20 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05249257 has completed, sponsored by Endo USA Inc., a Keenova Therapeutics Company.
- COMPLETED
- Registry status
- 20 participants
- Enrollment target
Study Summary
All participants who completed the EN3835-224 study will be invited to participate in this observational study to evaluate long term durability of response and safety.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2022-01-25 |
| Est. Completion | 2022-09-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05249257
The ClinicalTrials.gov registry entry for NCT05249257 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Endo USA Inc., a Keenova Therapeutics Company, which has 61 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT05249257 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05249257 about?
NCT05249257 is a clinical study titled "Durability and Safety of CCH With Two Different Injection Techniques in Cellulite With Laxity". All participants who completed the EN3835-224 study will be invited to participate in this observational study to evaluate long term durability of response and safety.
What is the current status of trial NCT05249257?
This trial is currently completed. The enrollment target is 20 participants. The study started on 2022-01-25. Estimated completion is 2022-09-12.
Who is sponsoring clinical trial NCT05249257?
This trial is sponsored by Endo USA Inc., a Keenova Therapeutics Company, which has 61 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.